Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for Enterocutaneous Fistulae in Crohn's Disease
NCT00004941Phase 3Completed
- Sponsor
- Food and Drug Administration
- Start
- Jul 1996
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in Crohn's disease, sponsored by Food and Drug Administration. Started Jul 1996; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00004941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004941.